EP 4247817 A1 20230927 - MACROCYCLES CONTAINING A 1,3,4-OXADIAZOLE RING FOR USE AS MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
Title (en)
MACROCYCLES CONTAINING A 1,3,4-OXADIAZOLE RING FOR USE AS MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
Title (de)
MAKROCYCLEN MIT EINEM 1,3,4-OXADIAZOLRING ZUR VERWENDUNG ALS MODULATOREN DES TRANSMEMBRANLEITUNGSREGULATORS BEI ZYSTISCHER FIBROSE
Title (fr)
MACROCYCLES CONTENANT UN CYCLE 1,3,4-OXADIAZOLE DESTINÉS À ÊTRE UTILISÉS EN TANT QUE MODULATEURS DU RÉGULATEUR DE LA CONDUCTANCE TRANSMEMBRANAIRE DE LA FIBROSE KYSTIQUE
Publication
Application
Priority
- US 202063115552 P 20201118
- US 2021072475 W 20211117
Abstract (en)
[origin: WO2022109573A1] This disclosure provides modulators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), pharmaceutical compositions containing at least one such modulator, methods of treatment of cystic fibrosis using such modulators and pharmaceutical compositions, and processes for making such modulators.
IPC 8 full level
C07D 498/18 (2006.01); A61K 31/439 (2006.01); A61P 11/00 (2006.01); A61P 43/00 (2006.01); C07D 498/22 (2006.01); C07D 513/22 (2006.01)
CPC (source: EP IL KR)
A61K 31/404 (2013.01 - KR); A61K 31/439 (2013.01 - KR); A61K 31/443 (2013.01 - KR); A61K 31/4439 (2013.01 - KR); A61K 31/47 (2013.01 - KR); A61K 31/529 (2013.01 - KR); A61K 45/06 (2013.01 - KR); A61P 11/00 (2018.01 - EP IL KR); A61P 43/00 (2018.01 - EP IL); C07D 498/18 (2013.01 - EP IL KR); C07D 498/22 (2013.01 - EP IL KR); C07D 513/22 (2013.01 - EP IL); A61K 2300/00 (2013.01 - KR)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2022109573 A1 20220527; AR 124090 A1 20230215; AU 2021383176 A1 20230622; CA 3201793 A1 20220527; CL 2023001398 A1 20231124; CN 116670140 A 20230829; CO 2023007896 A2 20230918; CR 20230260 A 20231005; DO P2023000099 A 20230815; EC SP23045439 A 20230831; EP 4247817 A1 20230927; IL 302873 A 20230701; JP 2023549547 A 20231127; KR 20230123522 A 20230823; MX 2023005721 A 20230725; PE 20231380 A1 20230907
DOCDB simple family (application)
US 2021072475 W 20211117; AR P210103184 A 20211118; AU 2021383176 A 20211117; CA 3201793 A 20211117; CL 2023001398 A 20230516; CN 202180090910 A 20211117; CO 2023007896 A 20230616; CR 20230260 A 20211117; DO 2023000099 A 20230517; EC DI202345439 A 20230616; EP 21843853 A 20211117; IL 30287323 A 20230511; JP 2023529022 A 20211117; KR 20237020002 A 20211117; MX 2023005721 A 20211117; PE 2023001653 A 20211117